Cargando…

Perioperative cardioprotection

Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no “magic bullet”, pharma...

Descripción completa

Detalles Bibliográficos
Autores principales: Leung, May KM, Irwin, Michael G
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Faculty of 1000 Ltd 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590787/
https://www.ncbi.nlm.nih.gov/pubmed/23513179
http://dx.doi.org/10.12703/P5-7
_version_ 1782261931828051968
author Leung, May KM
Irwin, Michael G
author_facet Leung, May KM
Irwin, Michael G
author_sort Leung, May KM
collection PubMed
description Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no “magic bullet”, pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients.
format Online
Article
Text
id pubmed-3590787
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher Faculty of 1000 Ltd
record_format MEDLINE/PubMed
spelling pubmed-35907872013-03-19 Perioperative cardioprotection Leung, May KM Irwin, Michael G F1000Prime Rep Review Article Although anaesthesia itself is now very safe, perioperative cardiac complications during non-cardiovascular surgery are a major cause of morbidity and mortality, because of the increasingly high underlying prevalence of cardiovascular disease. Fortunately, although there is no “magic bullet”, pharmacological intervention can reduce the risk. In particular, current evidence strongly supports the use of aspirin and statins. Beta blockers may also be beneficial in higher risk groups but need to be titrated to effect, and their use requires careful consideration because of adverse effects in these patients. Faculty of 1000 Ltd 2013-03-04 /pmc/articles/PMC3590787/ /pubmed/23513179 http://dx.doi.org/10.12703/P5-7 Text en © 2013 Faculty of 1000 Ltd http://creativecommons.org/licenses/by-nc/3.0/legalcode This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. You may not use this work for commercial purposes
spellingShingle Review Article
Leung, May KM
Irwin, Michael G
Perioperative cardioprotection
title Perioperative cardioprotection
title_full Perioperative cardioprotection
title_fullStr Perioperative cardioprotection
title_full_unstemmed Perioperative cardioprotection
title_short Perioperative cardioprotection
title_sort perioperative cardioprotection
topic Review Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3590787/
https://www.ncbi.nlm.nih.gov/pubmed/23513179
http://dx.doi.org/10.12703/P5-7
work_keys_str_mv AT leungmaykm perioperativecardioprotection
AT irwinmichaelg perioperativecardioprotection